Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1998 1
2000 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women.
Bonduki CE, Lourenço DM, Baracat E, Haidar M, Noguti MA, da Motta EL, Lima GR. Bonduki CE, et al. Acta Obstet Gynecol Scand. 1998 Mar;77(3):330-3. Acta Obstet Gynecol Scand. 1998. PMID: 9539282 Clinical Trial.
BACKGROUND: This study was performed to evaluate antithrombin III levels in postmenopausal women receiving hormonal replacement treatment. ...CONCLUSIONS: These data suggest that oral conjugated estrogen replacement reduces functio …
BACKGROUND: This study was performed to evaluate antithrombin III levels in postmenopausal women receiving ho …
Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin III and factor XII.
Gordon EM, Williams SR, Frenchek B, Mazur CA, Speroff L. Gordon EM, et al. J Lab Clin Med. 1988 Jan;111(1):52-6. J Lab Clin Med. 1988. PMID: 3335825 Clinical Trial.
The frequent use of estrogen and progestin replacement for treatment in postmenopausal women makes assessment of its effect on the coagulation system of interest. ...In this randomized prospective study, we examined the effects of varying low do …
The frequent use of estrogen and progestin replacement for treatment in postmenopausal women makes assessment of its …
Impaired procoagulant-anticoagulant balance during hormone replacement therapy? A randomised, placebo-controlled 12-week study.
van Baal WM, Emeis JJ, van der Mooren MJ, Kessel H, Kenemans P, Stehouwer CD. van Baal WM, et al. Thromb Haemost. 2000 Jan;83(1):29-34. Thromb Haemost. 2000. PMID: 10669150 Clinical Trial.
RESULTS: As compared to placebo, plasma levels of AT III were reduced only in the E2 group (approximately 28%), plasma levels of protein C decreased only in the E2+P group (approximately 4%) and plasma levels of protein S decreased in both the E2 and E …
RESULTS: As compared to placebo, plasma levels of AT III were reduced only in the E2 group (approximately 28%), plasma …